Replimune Group, Inc. (REPL)
NASDAQ: REPL · IEX Real-Time Price · USD
7.15
+0.03 (0.42%)
At close: Apr 16, 2024, 4:00 PM
6.99
-0.16 (-2.24%)
After-hours: Apr 16, 2024, 6:24 PM EDT

Replimune Group Income Statement

Millions USD. Fiscal year is Apr - Mar.
Year 2022202120202019201820172016
Selling, General & Admin
50.5538.7723.217.448.775.712.71
Research & Development
126.5379.5556.7538.7622.1713.526.94
Operating Expenses
177.08118.3179.9656.230.9519.239.65
Operating Income
-177.08-118.31-79.96-56.2-30.95-19.23-9.65
Interest Expense / Income
4.162.223.061.92000
Other Expense / Income
-7.24-2.5-2.15-5.49-0.110.47-1.94
Pretax Income
-174-118.04-80.87-52.63-30.83-19.7-7.7
Income Tax
0.29000000
Net Income
-174.28-118.04-80.87-52.63-30.83-19.7-7.7
Shares Outstanding (Basic)
585246342355
Shares Outstanding (Diluted)
585246342355
Shares Change
11.49%12.89%34.99%47.69%365.97%0.10%-
EPS (Basic)
-2.99-2.26-1.75-1.54-1.33-3.96-1.55
EPS (Diluted)
-2.99-2.26-1.75-1.54-1.33-3.96-1.55
Free Cash Flow
-130.32-84.52-63.78-67.09-27.98-16.15-7.32
Free Cash Flow Per Share
-2.24-1.62-1.38-1.96-1.21-3.24-1.47
EBITDA
-167.39-113.67-76.1-50.17-30.69-19.59-7.58
Depreciation & Amortization
2.452.151.710.530.150.110.12
EBIT
-169.84-115.81-77.81-50.71-30.83-19.7-7.7
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).